Asthma Treatment Escalation

The management of chronic bronchial asthma follows a stepwise approach based on symptom severity and control. Initial treatments often involve inhaled medications.

Reasoning for Oral Corticosteroid Use

Oral corticosteroids are potent anti-inflammatory medications typically reserved for more severe forms of asthma that are not adequately controlled with inhaled therapies.

• Mild Persistent Asthma: Generally managed with inhaled short-acting beta-agonists (SABA) as needed and possibly low-dose inhaled corticosteroids (ICS).
• Moderate Persistent Asthma: Often requires stepping up therapy, potentially including medium-dose ICS or adding a long-acting beta-agonist (LABA) alongside ICS.
• Severe Persistent Asthma: Requires high-dose ICS/LABA therapy. Oral corticosteroids may be considered if control remains poor.
• Very Severe Persistent Asthma: This represents the highest level of severity, where asthma remains uncontrolled despite optimized high-dose inhaled therapy. At this stage, oral corticosteroids are often a necessary component of the treatment regimen to achieve symptom control and prevent exacerbations.

Therefore, oral corticosteroids are best introduced when the asthma reaches the very severe persistent classification, indicating a need for systemic anti-inflammatory treatment.